Juanjo Cragnolini
Associate Director, Oncology Search & Evaluation Takeda Pharmaceutical
Juanjo Cragnolini, PhD, is an Oncology Search & Evaluation Lead at Takeda, where he focuses on identifying and advancing external innovation opportunities to strengthen the company’s oncology pipeline. Prior to joining Takeda, Juanjo held roles at GSK across Oncology R&D and Biopharma Discovery, including Associate Director within Partnerships & External Innovation. Juanjo’s background combines deep scientific expertise with business development acumen, with experience spanning CAR-T cell therapy, immuno-oncology, and biologics discovery. He trained at the Massachusetts Institute of Technology.
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion: Targeted Oncology Biologics
8:00 am
- Understanding what it takes for pharma to invest. What are the current budgetary considerations within pharma?
- How is pharma assessing novel technologies, and where do they place within portfolios?
- What feels differentiated in a crowded space? From pharma’s perspective, what will make something best-in-class?
